The foremost gathering of CEOs of international and local pharmaceutical producers, distributors and retailers

16 - 17 May 2017

Sponsors

Back to sponsors page
QuintilesIMS
Back to sponsors page
Transservice
Back to sponsors page
DSM Group
Back to sponsors page
Polysan
Back to sponsors page
AlphaRM
Back to sponsors page
Santens Service Group
Back to sponsors page
Aston Health
Back to sponsors page
STADA
Back to sponsors page
Pharmasyntez
Back to sponsors page
LEAD M&A PARTNER: Novus Capital
Back to sponsors page
Innovation Partner: R-Pharm
Back to sponsors page
PwC
Back to sponsors page
Baker McKenzie
Back to sponsors page
Boehringer Ingelheim
Back to sponsors page
Petrovax Pharm
Back to sponsors page
Covance
Back to sponsors page
Sintez
Back to sponsors page
BMP Media Audit
Back to sponsors page
SICPA
Back to sponsors page
Deloitte
Back to sponsors page
Lidings
Back to sponsors page
ORFE
Back to sponsors page
Pozitiv Bio
Back to sponsors page
IPSOS
Back to sponsors page
Aaron Lloyd
Back to sponsors page
Rx Code
Back to sponsors page
IPT Group
Back to sponsors page
Viseven
Back to sponsors page
GfK
Back to sponsors page
Navicon IT Consulting

Supporting Organisations

Back to sponsors page
-
Back to sponsors page
-
Back to sponsors page
RAAS

Information Partners

Back to sponsors page
Pharmvestnik
Back to sponsors page
Vademecum
Back to sponsors page
Remedium
Back to sponsors page
GMP News
Back to sponsors page
-
Back to sponsors page
-
Back to sponsors page
MediaMedika
Back to sponsors page
RIA AMI
Back to sponsors page
"Moscow pharmacies"
Back to sponsors page
PROVita
Back to sponsors page
-
Back to sponsors page
-
Back to sponsors page
-
Back to sponsors page
YellMed
Back to sponsors page
-
Back to sponsors page
-
Back to sponsors page
Interfax

QuintilesIMS (NYSE:Q) is a leading integrated information and technology-enabled healthcare service provider worldwide, dedicated to helping its clients improve their clinical, scientific and commercial results. Formed through the merger of Quintiles Transnational and IMS Health, QuintilesIMS’s approximately 50,000 employees conduct operations in more than 100 countries. Companies seeking to improve real-world patient outcomes through treatment innovations, care provision and access can leverage QuintilesIMS’s broad range of healthcare information, technology and service solutions to drive new insights and approaches. QuintilesIMS provides solutions that span clinical to commercial, bringing customers a unique opportunity to realize the full potential of innovations and advanced healthcare outcomes.

As a global leader in protecting individual patient privacy, QuintilesIMS uses healthcare data to deliver critical, real-world disease and treatment insights. Through a wide variety of privacy-enhancing technologies and safeguards, QuintilesIMS protects individual privacy while managing information to drive healthcare forward. These insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders in the development and approval of new therapies, and to identify unmet treatment needs and understand the safety, effectiveness and value of pharmaceutical products in improving overall health outcomes. To learn more, visit www.QuintilesIMS.com

Visit our website

TS TRANSSERVICE is an advanced logistics operator and member of PROTEK GROUP, providing a full range of  services for players in the Russian pharmaceutical market. This is a state-of-the-industry pharmaceuticals supply chain distribution center.
The storage and processing facilities with a capacity of 40,000 pallets are within a few miles reach north of Moscow. The DC has validated GDP and GSP certificates. It provides special temperature control storage conditions based on uninterrupted cold chain technology.
TS TRANSSERVICE is fully integrated with CV Protek’s distribution infrastructure, supplying customers with a wide range of customs clearance services, logistics services and warehousing services.
TS TRANSSERVICE has launched a dedicated 2015-2021 extension program to crank up the existing warehousing and distribution facilities. In April 2017 the company commissioned a new distribution terminal TRANSSERVICE-2. The total area of the pharmaceutical logistic park TRANSSERVICE will have reached 160,000 sq m and 250,000 pallets by 2021.

Visit our website

DSM Group has been active on the pharmaceutical market since 1999. The agency offers its clients a unique opportunity to use Retail Audit, Hospital, DLO (Supplemental Drug Coverage) Audit data in the CIS countries (Russia, Ukraine, Kazakhstan, Belarus, Moldova and others) in their daily work. The distinctive feature of DSM Databases is the data updating rate and data accuracy. The procedure of the Retail Audit processing meets ISO 9001:2000 requirements. DSM Group also provides a range of marketing services and regularly analyzes market capacity and trends, reporting them in newspapers and business magazines. In addition, DSM carries out surveys of pharmacists and doctors, conducts focus groups, customized researches and provides advertising support and conference service. Our clients are world leading pharmaceutical companies. Our data is used in state ministries and departments. Since 1999 DSM Group has been a member of the ESOMAR, The European Society for Opinion and Market Research.
More information is available on our website: www.dsm.ru.

Visit our website

STPF POLYSAN Ltd. was established in 1992. The company produces 4 original drug products: Cycloferon, Cytoflavin, Reamberin and Remaxol. POLYSAN has taken the Russian Federation Government awards in science & technology twice. Its own pharmaceutical plant, located in Saint-Petersburg, fully complies with the international requirements of PIC/S GMP (2015). Sales markets: Russia, CIS countries, South East Asia, Latin America.

Presently, POLYSAN is implementing localization projects for international companies’ drug  manufacture. POLYSAN has already initiated construction of the third stage of its pharmaceutical plant and designing of a scientific & research center.

Following its corporate values, POLYSAN allocates all scientific resources to protect life and health of patients.

Visit our website


The analytical company AlphaRM (est. 2015) consists of professional staff with a high level of expertise in the pharmaceutical market. The priority tasks performed by the company include restoring the structure of the retail pharmacy market and hospital segment. The following projects have been successfully completed and implemented to date:
• Geo-marketing sales monitoring on a map of the Russian Federation at all levels of product distribution (summarised information of regions and institutions, ratings, retail sales monitoring, and government procurement, including regional and federal benefits);
• Retail sales of medicines in pharmacies and health facilities at all levels (with extra details up to the administrative level);
• Monitoring federal and regional target programmes (with details by market segment);
• Monitoring public procurement of medicines in the Russian Federation (tenders database and express tenders).

Visit our website

Established in 2000, Santens Service group is one of the largest pharmaceutical operators in Russia. The group specializes in providing customs and logistics services for pharmaceutical products on the territory of the Russian Federation.
The group’s customers comprise both national and international manufacturers and distributors of pharmaceuticals and include Pfizer, Teva, Bayer, Novartis group, AstraZeneca, Valeant,  KRKA, Queisser Pharma, Eli Lilly, Boiron, Boehringer Ingelheim, ROSTA, Katren, Doctor Reddy’s Laboratories, Biotec, UCB Pharma, Ranbaxy, Abbott Laboratories, Orion Pharma, MSD Pharmaceuticals and Grindeks.
The company’s goal is to facilitate patients’ access to the best medicines and reduce the cost of treatment by introducing a new supply chain business model from manufacturer to patient.
We achieve our goal by further developing key competences and introducing new ones, ranging from service distribution and specialized logistics solutions to the development of medicine reimbursement technologies.
In 2016 the total storage capacity of the group amounted to 142,000 pallets. The total import turnover of Santens Service group’s clients exceeded $4.5 billion over the said period.
http://eng.santens.ru/

Visit our website

Acting in collaboration with the medical community, policy-makers, pharma and patient groups, Aston Health offers integrated set of solutions for healthcare delivery systems to improve access to quality care and promote innovative health technologies.

We are focused on public pharmaceutical sector and our research contributes to improving all aspects of healthcare. By integrating meaningful clinical and marketing information in a proprietary technology platform we provide solutions based on advanced knowledge and wealth of experience to effectively address our clients’ needs in medical, regulatory and commercial practice.

Visit our website

STADA Arzneimittel AG is a publicly-listed company which consistently focuses on a multi-pillar strategy of generics and branded products with an increasingly international market orientation.
Worldwide, STADA is represented in more than 30 countries with more than 50 subsidiaries.
Today the Russian portfolio includes more than 150 products of different ATC-classes and dosage forms which are manufactured by the leading Russian and international pharmaceutical companies – NIZHPHARM, Hemofarm LLC (Obninsk), STADA AG, Hemofarm A.D., Grünenthal etc.

STADA has a diversified organizational structure that consists of the pharmaceutical companies specializing in three major fields: R&D, production and marketing.

Visit our website

JSC Pharmasyntez has been in the pharmaceutical market since 1997. The company is focused on the development and production of pharmaceutical products for the treatment of socially significant diseases, such as TB, HIV/AIDS, hepatitis, oncological and blood diseases. The company is one of the largest manufacturers of antibiotics in Russia.

The company's mission is
• to produce effective drugs of high quality demanded by  modern medicine;
• to develop innovative pharma products;
• to increase the share of domestic drugs on the Russian market by substitution of imported analogues.
Pharmasyntez group structure:
• Irkutsk facility – JSC Pharmasyntez
• Ussuriysk facility – LLC EAST-PHARM
• Tyumen facility – LLC Pharmasyntez-Tyumen
• Bratsk facility – LLC BratskChemSyntez
• Saint Petersburg facility – JSC Pharmasyntez-Nord
Pharmasyntez is one of the top 10 leading pharmaceutical companies in Russia in terms of production growth and one of the top 3 fast-developing pharmaceutical enterprises on the Russian market.
The output of the Pharmasyntez group is 50 million packs per year
Its annual turnover: more than 10 billion rubles
Company's staff: 1500 highly skilled specialists
Three plants of the Pharmasyntez group in Irkutsk, Ussuriysk, and Tyumen are now producing 113 pharmaceutical products of different dosage forms and strengths: capsules, tablets, granules, infusion solutions, sterile dry powders and solutions for injection.

Investment activity:
A research and production complex for development and manufacture of anticancer and biotech drugs is being constructed in St. Petersburg; the 1st stage of construction is ongoing now; it is scheduled for commissioning in 2018.
In Bratsk, the construction of a plant for manufacturing active pharmaceutical ingredients is about to be completed, the full cycle production is scheduled for 2017, this will allow for the provision of a full cycle production of the company’s drugs.
To implement these plans, Pharmasyntez invests more than 5 billion rubles in the development of its own production facilities.

R&D:
Development of innovative pharma products and their introduction into a manufacturing process is a priority of the company. Annually, the Company invests up to 500 mln. rubles in scientific research. The company is continuously working towards finding New Molecular Entities for combating TB, HIV, and other diseases.
Annually, the Company synthesizes 300 to 500 new molecules.
Several years ago, a New Chemical Entity was developed for the treatment of multi-drug resistant tuberculosis (MDR-TB), and in 2015 it was listed as a VEN drug.
The phase II clinical trial of a radically new, first-of-its class pharmaceutical product for the prevention of adhesive disease is ongoing now.

Visit our website

Novus Capital is a leading regional investment banking firm in the pharmaceutical industry with a geographic focus on Russia, the CIS and the Baltic States. Novus Capital professionals have a broad experience in advising owners and foreign investors in M&A transactions and related activities (due diligence, structuring, negotiations etc.). In recent years, our team executed a number of cross border transactions in the pharmaceutical industry with a total value of USD 450 m, making our team the leading financial adviser to pharmaceutical companies in Russia.

Visit our website

JSC “R-Pharm” is a Russian high-technology pharm company. Its activities embrace areas related to development, research, production and bringing to market of a wide range of innovative medications primarily for hospital and specialized care. Today more than 3500 highly skilled professionals work in the company. In Russia there are over 60 business units and representative offices of the company. R-Pharm operates on the territory of CIS countries, USA, Germany, Japan, UAE, Turkey and India. The corporate structure includes pharm manufacturing facilities located in Yaroslavl, Kostroma region, Novosibirsk and Germany. A new advanced research and production complex on development of API’s in Rostov, biotech drug manufacturing plant in Turkey and the first pharm complex that comprises manufacturing, laboratory and logistics units in Azerbaijan are all under construction.

Address:
119421, Moscow, Leninsky Prospect, 111Б

Telephone: +7 (495) 956 79 37; +7 (495) 956 79 38
E-mail:info@rpharm.ru

Visit our website

PwC Russia (www.pwc.ru) provides industry-focused assurance, tax, legal and advisory services. Over 2,500 professionals working in PwC offices in Moscow, St
Petersburg, Ekaterinburg, Kazan, Rostov-on-Don, Krasnodar, Voronezh, Novosibirsk, Vladikavkaz and Ufa share their thinking, experience and solutions to develop fresh perspectives and practical advice for our clients.

 

 

Visit our website

For more than 65 years Baker McKenzie has been effectively providing global advice in the pharmaceutical sector, and for over 25 of those years providing such advice here in the CIS. The size and global reach of our Firm, with its 77 offices in 47 countries, guarantee that know-how is shared among jurisdictions and allow resources from our international network to supplement local office needs. Having assisted in the foundation of the Association of International Pharmaceutical Manufacturers and the International Medical Devices Manufacturers Association, we advise clients on the full spectrum of legal concerns in the CIS, including customs and trade regulation, as well as WTO and EurAsEC-consistent policy. (www.bakermckenzie.com)

Visit our website

Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates presently with a total of some 50,000 employees worldwide.

 

The focus of the family-owned company, founded in 1885, is on researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.

 

Social responsibility is an important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects through, for example, the initiative “Making More Health” while also caring for employees. Respect, equal opportunity and reconciling career and family form the foundation of mutual cooperation. The company also focuses on environmental protection and sustainability in everything it does.

 

In 2015, Boehringer Ingelheim achieved net sales of about 14.8 billion euros. R&D expenditure corresponds to 20.3 per cent of net sales.

 

For more information please visit www.boehringer-ingelheim.com

Visit our website

Petrovax Pharm is the leading Russian R&D and manufacturing company focusing on innovative pharmaceutical products and vaccines. The company was founded in 1996 by Prof. Arkady Nekrasov and a group of Russian chemists, biologists and biotechnologists.

NPO Petrovax Pharm’s product portfolio includes only innovative pharmaceuticals and vaccines manufactured based on in-house R&D results and in partnership with the leading domestic and foreign companies. NPO Petrovax Pharm has more than 20 patents for new molecules and manufacturing technologies. The company's major activities include the development and manufacture of influenza vaccines and immunobiological products as well as the manufacture of a pneumococcal vaccine.

NPO Petrovax Pharm is a full-cycle pharmaceutical company whose manufacturing unit is fully compliant with Russian and international GMP standards and ISO:9001. The up-to-date manufacturing complex located in the Moscow region is one of the most sophisticated hi-tech biopharmaceutical facilities in Russia.
NPO Petrovax Pharm has more than 600 highly skilled employees. NPO Petrovax Pharm is part of Interros Group.

22 Krasnaya Presnya St.,
Moscow, 123022, Russia
Tel./Fax: +7 (495) 730-75-45/60
E-mail: info@petrovax.ru
www.petrovax.ru

Visit our website

Covance, the drug development business of LabCorp, is the world’s most comprehensive drug development company. We’re dedicated to advancing healthcare by providing high-quality nonclinical, clinical and commercialization solutions to pharmaceutical and biotechnology companies to help reduce the time and costs associated with drug development.
Biopharma Solutions:
• Covance MarketPlace: Gain visibility and forge the right connection with potential partners, while safeguarding your asset through a unique online networking solution.
• Early Phase Development Solutions: Advance your program seamlessly from nonclinical through first-in-human and proof-of-concept phases with a single, dedicated team of development experts.
• Commercial Market Access: Build your asset’s clinical/economic value dossier, one that resonates with payers, providers, patients, investors and potential pharma partners.
Let’s discuss how we can help you succeed – with continuity, partnership and flexibility.
Visit www.covance.com

Visit our website

PLC “Kurgan Joint-stock Company of Medical Supplies and Products “Sintez”, one of the largest pharmaceutical factories in Russia, is included in the top-ten leading Russian enterprises. Every 10th local medical product is made by "Sintez". The company occupies approx. 60% of the Russian antibiotics market (Cephalosporin series). In 2016 "Sintez" was recognized as the best company in terms of sales growth on the national market.

“Sintez” complies with GMP standards requirements, produces APIs, medicines and medical products from polymeric materials. The range of commodity contains 300 SKU. More than 30% of products are made from “Sintez’s” ownAPIs, including natural and semi-synthetic antibiotics. Half of the company’s product portfolio consists of drugs from the VED list. The company exports medicines to 15 different countries.

“Sintez” is one of the largest enterprises of the Kurgan region, providing 7% of GRP.

Visit our website

"Marathon Pharma" Group of Companies was established in 2017 to manage the pharmaceutical assets of the investment company "Marathon Group", founded by Alexander Vinokurov and Sergei Zakharov.

"Marathon Pharma" includes one of the largest Russian distributors of medicines "SIA Group", the factories of PLC "Kurgan Joint-stock Company of Medical Supplies and Products" Sintez "and JSC" Biocom ",  a manufacturer of hand sanitizers Bentus Laboratories LLC (brand Sanitelle) and pharmacy stores "Mega Pharm" (brands "A-Mega" and "Da Zdorov!").

Visit our website

BMP Media Audit is a young, dynamically growing company. Established in 2013, BMP Media Audit specialises in providing media consulting and media audit services to the Russian market. Today, the number of clients exceeds 40, half of which are pharmaceutical companies with an annual media budget ranging  from 100 mln  to more than 1 bln roubles. The main goal – to increase the effectiveness of the client’s media placement investments. The main activities – undertaking media tenders, panning audit, evaluation of the media deal prices and quality, analysis of the media partner’s execution of the price, quantitative and qualitative parameters of the media deal including the calculation of compensations and also special training programs for  marketing and purchasing units specialists. Among thecompany’s clients are VTB24, Evalar, Leroy Merlin, Infamed, Renewal, Egis, Polpharma, UCB, etc. BMP Media Audit is the official partners of the global media auditor Media Path Network

Visit our website

SICPA, a global leader in authentication, identification and secure traceability solutions and services, was founded in Switzerland in 1927 and partners with governments, financial institutions, businesses and industries worldwide on matters related to security.

A profound knowledge of the business environment combined with significant experience and understanding of issues related to illicit trade have enabled SICPA to provide expertise to businesses in a diverse range of industries including pharmaceutical, agro-nutrition, luxury goods, automobile and the fast moving consumer goods industry.

Visit our website

Deloitte, CIS has been operating for more than 25 years in Russia and is one of the leading international professional services firms, offering audit, consulting, corporate finance, enterprise risk, and tax and legal services and leveraging the professional experience of approximately 2,500 employees in 18 offices located in 11 countries across the region.
Today, Deloitte, CIS has offices in Moscow, St. Petersburg, Ufa, Yekaterinburg, Novosibirsk, Yuzhno- Sakhalinsk, Baku, Tbilisi, Yerevan, Kyiv, Minsk, Almaty, Astana, Aktau, Atyrau, Ashgabat, Bishkek, Dushanbe, and Tashkent.

Visit our website

Lidings is a leading independent national law firm advising Russian and international companies with different industrial background on all legislative aspects of doing business in Russia and CIS. Specializing in all key practice areas we advise market leaders, international investors, representatives of medium and large global businesses interested in entering the Russian and CIS market and in actively implementing a variety of business and commercial projects in Russia.
Pharmaceuticals and Healthcare practice is one of Lidings’ most rapidly developing practice areas. The firm’s clients are recognized leaders of the pharmaceutical market, such as AstraZeneca, Boehringer Ingelheim, Merck, Ipsen Pharmaceuticals, Astellas Pharma, Mallinckrodt Pharmaceuticals, MEDA Pharmaceuticals, Sanofi, Grindex and many others. The firm frequently initiates and supports major international conferences devoted to issues most essential for the pharmaceutical industry in Russia and abroad. Lidings’ lawyers are annually recognized for their expert industry knowledge by such international legal directories as Chambers and Partners, The Legal 500 EMEA, Who is Who Legal, LMG Life Sciences and others.

Visit our website

Orfe’s mission is to deliver a logistical and legal platform to foreign pharmaceutical companies, providing them with a legal and infrastructure base to conduct business in Russia.
Orfe was founded in 1994. Each year, the company has strengthened its position as a reliable and stable partner in the Russian pharmaceutical market.
Today, Orfe operates as a 3PL provider delivering a full range of services to the customers, including customs clearance, declarations of conformity, bonded storage and pharmaceutical warehousing, and acts as an importer and wholesale distributor for European manufacturers of high quality pharmaceutical products.
Given vast experience, the company has become a crucial link in the pharmaceutical products supply chain, connecting the Russian pharmaceutical market and Western manufacturers.
In 2016, Orfe entered a strategic agreement with DHL Supply Chain, to access the international reach of DHL, and enlarge the scope and geographical coverage of our services. http://orfe.ru/

Visit our website

Pozitiv BIO has been an active participant of the pharmaceutical market for 10 years and is an exclusive distributor of natural products for health, beauty and longevity.
Our products benefit all people, are of the highest quality, available on the shelves of all pharmacy chains and from large pharmaceutical distributors, having a mutually beneficial cooperation with many wholesale companies in Russia and CIS.
Products include brands in the field of male health such as “Lovelas Forte”, “Semental” and “Yarsagumba Forte”, the natural antidepressant “POZITIV”, a complex for protection and normalization of vision “ORLIT” and horse balsam – an essential aid for articulations and muscles.
By carefully selecting products, attracting serious partners, and conducting large-scale advertising campaigns, we have the capacity to develop strong brands that are readily sold and used by inhabitants throughout Russia’s regions.
Doing business with us is profitable and durable! We know which niches will sell well and we can share our knowledge with you.
The scope of activity includes advertising on TV and in magazines with the participation of show-business stars, providing partners with promotional materials and professional support of sales representatives.
We provide a flexible commercial policy for the wholesale supply and retro-bonus system for pharmacy chains. We provide the delivery of our products to the warehouses of our partners.
We are happy to work with you and for you!
Be always positive!

www.NAPOZITIVE.ru

Visit our website

McKinsey & Company is a global management consulting firm. We serve leading corporations, government agencies, international financial organizations and cultural institutions. We help our clients accomplish large-scale and significant transformations to boost operating efficiency and deliver outstanding and sustainable results. The company currently has more than 100 offices in 60 countries around the globe. In 1993, McKinsey was the first international consulting firm to move into Russia. Since then, it has completed around 1,500 projects for companies in all major industries.

Visit our website

Ipsos Healthcare Russia, as a part of the Global Ipsos Healthcare, has been specializing on the Russian Healthcare market for more than two decades and works with most  market players and their HQs.
A deep understanding of the Russian healthcare and pharmaceutical market coupled with a wide range of analytical services and modern research tools allows us to keep a leading position in this segment.
There are almost 50 employees at Ipsos Healthcare (Russia) focusing exclusively on Healthcare research and offering a full range of services in the following areas: Syndicated research, Custom research (AdHoc), Analytics and consultancy and Educational trainings.
Our Syndicated Surveys cover over 15 000 physicians and more than 4 500 pharmacists annually, providing our clients with actual and precise data on the Russian pharmaceutical market.
Custom research both for Qualitative and Quantitative parts as well as support from our Analytics&Consultancy service allow our clients to be updated regularly on market feedback on various segments.
The educational project, the School of Pharmaceutical Marketing has, within the last 9 years, been offering a wide range of educational workshops and training programs conducted by leading trainers and market experts.

Visit our website

The communication group «Aaron Lloyd» is a media agency, working in the pharmaceutical market since 1999.
We have a lot of expert employees, including a Medical director, who provide additional support to our clients in relation to marketing.
We are involved in strategic and tactical media-planning, econometric modelling and implement unusual projects and 360° campaigns. We also provide educational programs for our Clients.
«Aaron Lloyd» agency is the only subscriber for industrial data from QuintilesIMS and Alpharm.
From 2014 the agency has been a strategic partner of Dentsu Aegis Network group in Russia.
From 2016 a special medical program «Agents 003» is broadcast on TNT channel with involvement of the Agency «Aaron Lloyd».

Visit our website

The marketing agency RX Code is one of the leaders in the Russian market of pharmaceutical products and medical equipment promotion.
The company is an expert in the provision of services for personnel outsourcing, remote communication with doctors and pharmacies, organization of training courses and special social projects, as well as in creative solutions for all types of media.

Visit our website

 

IPT Group has been providing legal and financial support to businesses for over 12 years, advising over 100 companies working across 20 different industry sectors.

IPT Group has gained a unique experience in the Medical and Pharmaceutical sector where our clients include leading international and Russian pharmaceutical companies.

In 2016 we successfully completed one of the most significant deals in pharmaceutical localistation and the creation of one of the largest joint enterprises in the sphere of biotechnology.

IPT Group is a member of the Global Law Experts legal association. The company is a TOP-50 legal company in Russia, according to Pravo.ru-300 and according to the INTL Corporate magazine, IPT Group was nominated top legal firm in the pharmaceutical and healthcare sector in 2016.

Visit our website

Here at Viseven we know how to run a digital marathon and reach highest business goals with Digital Content Factory – a new type of cooperation between Global Marketing Team, Local Teams and Digital Agencies.
Empower marketing and commercial teams to tackle the digitalization challenge and ensure maximum profitability.
Solve the scalability challenges with a platform that supports decentralized execution with centralized governance.
Reduce costs and drive efficiency by standardizing the processes, based on eWizard platform, which enables easy skillset adoption, likewise content and components reuse. Save time and budget for email templates creation, mobile apps and eDetailing development, localization and distribution to quickly respond to any market changes.

Visit our website

GfK is the trusted source of relevant market and consumer information that enables its clients to make smarter decisions. More than 13,000 market research experts combine their passion with GfK’s 80 years of data science experience. This allows GfK to deliver vital global insights matched with local market intelligence from more than 100 countries. By using innovative technologies and data sciences, GfK turns big data into smart data, enabling its clients to improve their competitive edge and enrich consumers’ experiences and choices.
In Russia GfK delivers vital insights on consumer experience and choices in such industries like FMCG, Retail, Health, Telecommunications, Automotive business, Banking, Insurance and Finance, Media, Consumer Electronics and other markets.

 

Visit our website

Navicon is a system integrator and a leading company in IT consulting and project management in Russia. The company was founded in 2002. Navicon completed more than 300 successful projects for Russian and international companie. The key business lines are budgeting, business analytics, big data management, accounting automation, client relationships, electronic portal and archive development, integration and master data management solutions, as well as IT rollouts for global companies in Russia. Produc line: ERP (Microsoft Dynamics NAV, Microsoft Dynamics AX); CRM (Microsoft Dynamics CRM); BPM (IBM Cognos, IBM SPSS); BI (IBM Cognos BI, Microsoft BI); Integration services (Microsoft BizTalk Server). Navicon customers: Nycomed, R-Pharm, Akrikhin, Jonson&Jonson, AstraZeneca, BAYER, Sotex, Novartis, Sanofi, Takeda etc.

Visit our website

Established in 1994. The Association comprises 60 international pharmaceutical companies that provide over 80% of the world’s pharmaceutical products and over 60% of medicines imported to the Russian Federation.

AIPM Mission

To promote economic and legal policies that focus on the development of organized and open pharmaceutical market, improving of medical services quality and expansion of the range of modern medicines for the benefit of Russian people.

Visit our website

http://www.en.arfp.ru/

Visit our website

http://spfo.ru/

Visit our website

http://sojuzpharma.ru/

Visit our website

http://www.raas.ru/

Visit our website

”Pharmvestnik” (Pharmaceutical Bulletin) is the leading specialized weekly newspaper covering the Russian pharmaceutical industry with a certified circulation of 16 200 copies. The 20 year-long first-hand pharma market experience has made it a reliable source of professional information for all types of market players – manufacturers, distributors, pharmacies, regulators – as well as the pharmaceutical and medical communities at large.
”Pharmvestnik” carries opinions of market leaders, leading experts, authorities, and public organizations.
It covers the Russian pharma market analysis by sector, regulatory activities as well as offers practical advice valuable in the pharmacist’s and HR manager’s perspective. Equal coverage is also given to all Russia’s federal districts as ”Pharmvestnik” has regional representatives in all largest cities and towns.
Since 2013, the “PhV-Analytics” series has been published under ”Pharmvestnik” umbrella brand. It includes a digital quarterly collection of analytical reports on all aspects of the pharma market functioning and a hard-copy annual report.

Visit our website

http://www.vademec.ru/

Visit our website

Remedium group of Companies renders the whole range of services for specialists in the field of medicine and pharmaceutics. For years the principle directions of activity of “Remedium” Group of Companies are publication of particularized periodicals, assignment of electronic databases, arrangement and implementation of measures, rent-a-rep service, organization of advertisement and PR support.

Visit our website

Research and production reviewed journal "Drug Development & Registration" is actual free applied edition for the pharmaceutical experts.

Companies and their employees from production, development, research, quality control and registration departments; staff of the laboratories, contract research organizations, scientific and educational centers and universities are our target audience. Now the journal has more than 16 000 subscribers. Publications are distributed at all key pharmaceutical, chemical and technological actions (seminars, conferences and exhibitions). The journal is read and discussed in all cities of Russia. There are residents in Russia, CIS and Europe among subscribers of journal.

Four main subject parts of the journal "Drug Development & Registration" include drug development cycle from its synthesis till getting drug registration certificate. The first part is devoted to pharmaceutical technology and surveys the scientific and practical issues from extraction and production of  pharmaceutical substances, technologies and equipment to standard medical products manufacture; the subject of the second part is the study of  analytical procedure of quality control; the third examines approaches to the drug quality and safety evaluation and the fourth part describes questions regarding validation of methods, preparing registration data and drug life cycle in GxP environment.

Visit our website

http://gmpnews.ru/

Visit our website

www.farmsouz.ru

Visit our website

http://promoboz.com

Visit our website

http://www.con-med.ru/

Visit our website

http://riaami.ru/

Visit our website

«Moscow pharmacies». Published since 1995.

Professional information for chemist’s specialists, managers of pharmacy’s company.

Each issue has:

  • Hot topics of the industry;
  • Expert opinion of the pharmaceutical business;
  • Monitoring and ratings of the pharmaceutical market;
  • Review of the assortment;
  • Business training and consult of managers and employees of pharmacies.

Visit our website

http://www.vita-plus.ru/

Visit our website

http://www.vita-plus.ru/

Visit our website

http://med.vesti.ru/

Visit our website

Yellmed - is:

a catalog of Russian and foreign medical establishments with an actual and reliable information;
Russian and international medical, sports and beauty news;
interviews with experts;
medical events and conferences;
medical reference book with common diseases and it's sympthoms, methods of diagnosis and treatment;
doctor apointments in Moscow.
Yellmed - all about Russian medicine and more!

Visit our website

http://vrachivmeste.ru/

Visit our website

Interfax is the biggest information group in the CIS and the recognized leader in the B2B segment of Russia’s information market.

Interfax is the most frequently cited source for information on Russia and the CIS in the foreign press.

Interfax develops professional information solutions that help companies operate in the financial and commodity markets, enabling them to reach investment decisions, manage risk, organize external communications and fulfill regulatory requirements.

Visit our website